Ascelia Pharma AB (publ) (ACE) — Financial Flexibility Index
Ascelia Pharma AB (publ) (ACE) has a Financial Flexibility Index of -0.71x as of September 2025. Free cash flow of Skr-15.60 Million (operating CF Skr-15.66 Million minus capex Skr57.00K) represents -1% of total liabilities (Skr22.01 Million). Also explore Ascelia Pharma AB (publ) (ACE) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascelia Pharma AB (publ) Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Ascelia Pharma AB (publ) across 8 annual periods. Check Ascelia Pharma AB (publ) (ACE) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ascelia Pharma AB (publ) (2017–2024)
Year-by-year free cash flow to debt coverage for Ascelia Pharma AB (publ). For the full company profile including market capitalisation, see ACE company net worth.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.01x | Skr-62.84 Million | Skr-62.84 Million | Skr61.98 Million | — |
| 2023 | 0.00x | Skr0.00 | Skr-126.79 Million | Skr12.74 Million | ▲ +100.0% |
| 2022 | -3.32x | Skr-125.20 Million | Skr-125.26 Million | Skr37.71 Million | ▲ +26.9% |
| 2021 | -4.54x | Skr-116.52 Million | Skr-116.56 Million | Skr25.66 Million | ▼ -3.0% |
| 2020 | -4.41x | Skr-85.13 Million | Skr-85.53 Million | Skr19.32 Million | ▼ -58.8% |
| 2019 | -2.77x | Skr-36.52 Million | Skr-36.92 Million | Skr13.16 Million | ▼ -5.1% |
| 2018 | -2.64x | Skr-29.94 Million | Skr-30.33 Million | Skr11.35 Million | ▲ +43.3% |
| 2017 | -4.65x | Skr-20.56 Million | Skr-20.96 Million | Skr4.42 Million | — |